Nuklearmed Nucl Med
-
Nuklearmed Nucl Med · Apr 1999
[Reduction of radiation exposure in PET examinations by data acquisition in the 3D mode].
Modern volume PET systems offer the possibility to measure without the shadowing effect of interplane septa (2D mode) and thus to detect coincident events between detectors on distant rings (3D mode). It was the aim of the present paper to characterize the count rate behaviour of a latest-generation whole-body PET system in the 2D and 3D mode as well as to discuss the consequences for the radiation hygiene of PET examinations with 2-[F-18]-fluoro-2-deoxyglucose (18-F-FDG). ⋯ By using the 3D data acquisition mode, it is possible to markedly reduce the amount of activity to be applied to the patient and nevertheless to improve image quality. In our experience, it is sufficient to administer an activity of 150-200 MBq for whole-body examinations with F-18-FDG, which results in an effective equivalent dose of 3 or 4 mSv, respectively.
-
Nuklearmed Nucl Med · Jan 1998
Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
FDG-PET and MIBI-scintigraphy with SPECT were compared to [131I]-whole-body scintigraphy (WBS) and morphologic imaging in the follow-up of differentiated thyroid cancer. Their influence of therapy-planning was analysed. ⋯ WBS cannot be replaced by FDG-PET or MIBI-scintigraphy; neither of the latter was better than the other. Rising Tg-levels, negative WBS and the exclusion of pulmonary metastases by spiral-CT define the constellation in which FDG-PET and MIBI-scintigraphy can provide data of therapeutic relevance.
-
Nuklearmed Nucl Med · Oct 1997
Case Reports[Thyroid hormone resistance: variable clinical manifestations in five patients].
The syndrome of thyroid hormone resistance (RTH) is characterised by elevated circulating thyroid hormones, unsuppressed TSH levels and peripheral refractoriness to hormone action. Patients with RTH may be clinically hyperthyroid if the pituitary gland is more insensitive than other tissues to thyroid hormones. More often, patients have peripheral tissue resistance as well and are euthyroid. RTH is related to point mutations in the T3-binding domain of the beta-receptor gene. We report the variable clinical and biochemical features of five patients with RTH. ⋯ RTH has to be considered in all patients with inappropriate TSH secretion. The clinical manifestation of patients with RTH is heterogenous. Thyroid antibody measurements should be performed regularly in order to detect the development of coexisting autoimmune thyroid disease.